I'm not aware of any news for this immuno onc conference. happy to be corrected. I think it would be a just a forum for IMM to present existing data for peers and gather more attention.
ASCO in June will be a big event, complete result from AIPAC, which determines the next steps on it's way to reg approval. more mature data from non small cell lung cancer and head and neck cancer, and the potential of breaking a deal earlier than what Bell Porter applied in their valuation model. it's going to be super exciting.
Ann: Half Yearly Report and Accounts, page-33
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
46.5¢ |
Change
0.005(1.09%) |
Mkt cap ! $552.8M | |||
| Open | High | Low | Value | Volume |
| 47.0¢ | 48.5¢ | 46.0¢ | $1.287M | 2.727M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 147898 | 46.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 48.0¢ | 260072 | 5 |
View Market Depth
| Last trade - 16.10pm 09/05/2024 (20 minute delay) ? |
|
|||||
|
Last
46.8¢ |
Change
0.005 ( 0.97 %) |
||||
| Open | High | Low | Volume | ||
| 48.0¢ | 48.0¢ | 46.3¢ | 457961 | ||
| Last updated 15.59pm 09/05/2024 ? | |||||
| IMM (ASX) Chart |